Correlation Between ProMIS Neurosciences and Sutro Biopharma
Can any of the company-specific risk be diversified away by investing in both ProMIS Neurosciences and Sutro Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ProMIS Neurosciences and Sutro Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ProMIS Neurosciences and Sutro Biopharma, you can compare the effects of market volatilities on ProMIS Neurosciences and Sutro Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ProMIS Neurosciences with a short position of Sutro Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of ProMIS Neurosciences and Sutro Biopharma.
Diversification Opportunities for ProMIS Neurosciences and Sutro Biopharma
0.46 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between ProMIS and Sutro is 0.46. Overlapping area represents the amount of risk that can be diversified away by holding ProMIS Neurosciences and Sutro Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sutro Biopharma and ProMIS Neurosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ProMIS Neurosciences are associated (or correlated) with Sutro Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sutro Biopharma has no effect on the direction of ProMIS Neurosciences i.e., ProMIS Neurosciences and Sutro Biopharma go up and down completely randomly.
Pair Corralation between ProMIS Neurosciences and Sutro Biopharma
Considering the 90-day investment horizon ProMIS Neurosciences is expected to generate 1.63 times more return on investment than Sutro Biopharma. However, ProMIS Neurosciences is 1.63 times more volatile than Sutro Biopharma. It trades about -0.01 of its potential returns per unit of risk. Sutro Biopharma is currently generating about -0.03 per unit of risk. If you would invest 519.00 in ProMIS Neurosciences on October 22, 2024 and sell it today you would lose (430.00) from holding ProMIS Neurosciences or give up 82.85% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
ProMIS Neurosciences vs. Sutro Biopharma
Performance |
Timeline |
ProMIS Neurosciences |
Sutro Biopharma |
ProMIS Neurosciences and Sutro Biopharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with ProMIS Neurosciences and Sutro Biopharma
The main advantage of trading using opposite ProMIS Neurosciences and Sutro Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ProMIS Neurosciences position performs unexpectedly, Sutro Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sutro Biopharma will offset losses from the drop in Sutro Biopharma's long position.ProMIS Neurosciences vs. biOasis Technologies | ProMIS Neurosciences vs. Zenith Capital Corp | ProMIS Neurosciences vs. Hemogenyx Pharmaceuticals Plc | ProMIS Neurosciences vs. Fennec Pharmaceuticals |
Sutro Biopharma vs. Vaxcyte | Sutro Biopharma vs. Larimar Therapeutics | Sutro Biopharma vs. Syndax Pharmaceuticals | Sutro Biopharma vs. Merus BV |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Complementary Tools
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
FinTech Suite Use AI to screen and filter profitable investment opportunities |